Considering participation in a clinical trial is often a very difficult decision for patients, especially those dealing with a rare disease.
Considering participation in a clinical trial is often a very difficult decision for patients, especially those dealing with a rare disease. In this video, leading CTCL experts address the question of when a patient should consider entering a clinical trial.
The video features expert insights from:
This video is one of several featured in the CLF’s Online Learning Center. Other topics include recommendations for managing itch and a three-part overview of treatments for cutaneous lymphoma.
For more information, visit http://www.clfoundation.org/online-learning-center.
FDA Grants Pirtobrutinib Accelerated Approval to Treat CLL/SLL in the Third Line
December 2nd 2023The FDA has approved the non-covalent BTK inhibitor, pirtobrutinib, to treat patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have already undergone 2 lines of therapy.